Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2010 May;55(5):1385-90.
doi: 10.1007/s10620-009-0854-9. Epub 2009 Jun 9.

The Effect of Enteric-Coated, Delayed-Release Peppermint Oil on Irritable Bowel Syndrome

Affiliations
Randomized Controlled Trial

The Effect of Enteric-Coated, Delayed-Release Peppermint Oil on Irritable Bowel Syndrome

Shahin Merat et al. Dig Dis Sci. .

Abstract

Herbal remedies, particularly peppermint, have been reported to be helpful in controlling symptoms of irritable bowel syndrome (IBS). We conducted a randomized double-blind placebo-controlled study on 90 outpatients with IBS. Subjects took one capsule of enteric-coated, delayed-release peppermint oil (Colpermin) or placebo three times daily for 8 weeks. We visited patients after the first, fourth, and eighth weeks and evaluated their symptoms and quality of life. The number of subjects free from abdominal pain or discomfort changed from 0 at week 0 to 14 at week 8 in the Colpermin group and from 0 to 6 in controls (P < 0.001). The severity of abdominal pain was also reduced significantly in the Colpermin group as compared to controls. Furthermore, Colpermin significantly improved the quality of life. There was no significant adverse reaction. Colpermin is effective and safe as a therapeutic agent in patients with IBS suffering from abdominal pain or discomfort.

Similar articles

See all similar articles

Cited by 29 articles

See all "Cited by" articles

References

    1. Br J Radiol. 1995 Aug;68(812):841-3 - PubMed
    1. Am Fam Physician. 2005 Dec 15;72(12):2501-6 - PubMed
    1. Dig Liver Dis. 2007 Jun;39(6):530-6 - PubMed
    1. Gastroenterology. 2000 Sep;119(3):654-60 - PubMed
    1. Arzneimittelforschung. 1996 Dec;46(12):1149-53 - PubMed

Publication types

LinkOut - more resources

Feedback